All News
Abridge raises $250 million highlighting ‘billable notes’
In this edition of STAT Health Tech: HHS cuts impacting AI regulation at FDA, ambient scribe company Abridge's fundraise, and more.
Read MoreBiogen partners with Stoke Therapeutics to sell severe epilepsy drug
And other biotech stories from the past weekend.
Read MoreTrump Cuts Target CDC Training; Bird Flu Admissions Rise; Ozempic Theft Spree
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Duchenne gene therapy from Solid Biosciences produces promising results in early study
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Read MoreSTAT+: Biogen partners with Stoke Therapeutics on drug for severe epilepsy
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
Read MoreCould SSRIs protect against infections? A mouse study has hints
Massive federal health cuts, CDC data backup, and other essential health news stories from the weekend.
Read MoreJupiter Hospital Thane and CII host inaugural conclave on sustainability in healthcare
The event aimed to raise awareness, initiate action, and chart a course toward sustainable healthcare practices
Read MoreWhat I learned from a lovely woman on a packed ward in hospital | Zoe Williams
Healthy people are being forced to stay in hospital because of a lack of social care – and it’s an indictment of our current systemPoliticians talk constantly about the crisis in social care, and
Read MoreKerala Govt, Remidio launch Nayanamritham 2.0, an AI-assisted chronic eye disease screening programme
The programme extends across community health centres, taluk hospitals, and district hospitals, making comprehensive eye care available at all levels of the healthcare system
Read More